NEXLIZET Trademark

Trademark Overview

On Friday, October 5, 2018, a trademark application was filed for NEXLIZET with the United States Patent and Trademark Office. The USPTO has given the NEXLIZET trademark a serial number of 88145092. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Esperion Therapeutics, Inc.. The NEXLIZET trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of metabolic disease
nexlizet

General Information

Serial Number88145092
Word MarkNEXLIZET
Filing DateFriday, October 5, 2018
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6175773
Registration DateTuesday, October 13, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of metabolic disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 16, 2018
Primary Code005
First Use Anywhere DateThursday, June 4, 2020
First Use In Commerce DateThursday, June 4, 2020

Trademark Owner History

Party NameEsperion Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAnn Arbor, MI 48108
Party NameEsperion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAnn Arbor, MI 48108
Party NameEsperion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAnn Arbor, MI 48108

Trademark Events

Event DateEvent Description
Thursday, January 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 9, 2018NEW APPLICATION ENTERED
Tuesday, October 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 16, 2019ASSIGNED TO EXAMINER
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Friday, October 11, 2019SOU TEAS EXTENSION RECEIVED
Friday, October 11, 2019SOU EXTENSION 1 FILED
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 11, 2019SOU EXTENSION 1 GRANTED
Tuesday, July 28, 2020SOU EXTENSION 3 FILED
Tuesday, October 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 27, 2020SOU TEAS EXTENSION RECEIVED
Friday, March 27, 2020SOU EXTENSION 2 FILED
Friday, March 27, 2020SOU EXTENSION 2 GRANTED
Tuesday, March 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 28, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, July 28, 2020SOU TEAS EXTENSION RECEIVED
Thursday, August 13, 2020SOU EXTENSION 3 GRANTED
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Monday, October 13, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 9, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 28, 2020USE AMENDMENT FILED
Thursday, August 13, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 8, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

nexlizet disease metabolic treatment preparations pharmaceutical